ArticleFrontiers in oncology2022

Transmembrane Protein-Based Risk Model and H3K4me3 Modification Characteristics in Lung Adenocarcinoma.

Tao Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.